Quality risk management: putting GMP controls first

…, A Greene, M Zwitkovits, N Calnan - PDA Journal of …, 2012 - journal.pda.org
This paper presents a practical way in which current approaches to quality risk management
(QRM) may be improved, such that they better support qualification, validation programs, …

[BOOK][B] A Lifecycle Approach to Knowledge Excellence in the Biopharmaceutical Industry

N Calnan, MJ Lipa, PE Kane, JC Menezes - 2017 - books.google.com
This book addresses the rapidly emerging field of Knowledge Management in the pharmaceutical,
medical devices and medical diagnostics industries. In particular, it explores the role …

Knowledge Management as a Pharmaceutical Quality System Enabler: How Enhanced Knowledge Transfer Can Help Close the ICH Q10 to ICH Q12 Gap

MJ Lipa, A Greene, N Calnan - PDA journal of pharmaceutical …, 2021 - journal.pda.org
Knowledge management (KM) is identified in ICH Q10 (Pharmaceutical Quality System), as
a key enabler to the pharmaceutical quality system (PQS). ICH Q8 (Pharmaceutical …

FDA Quality Metrics Research-3rd Year Report

…, S Köhler, S Eich, LJ Macuvele, M Ritz, N Calnan… - 2019 - alexandria.unisg.ch
This report presents the findings from three years of Quality Metrics Research and builds on
seminal outcomes from earlier operations and quality management research, eg Voss et al.(…

Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9

N Calnan, K O'Donnell, A Greene - PDA Journal of Pharmaceutical …, 2013 - journal.pda.org
This article is the first in a series of articles that will focus on understanding the
implementation essentials necessary to deliver operational excellence through a International …

FDA Quality Metrics Research Final Report

T Friedli, S Köhler, P Buess, P Basu, N Calnan - 2017 - alexandria.unisg.ch
The FDA Quality Metrics initiative has emerged directly from the FDA Science and Innovation
Act (US Congress, 2012)(FDASIA, 2012) and aims to provide both industry and regulators …

An Academic Perspective: Knowledge Management: The Orphan Enabler—Enabling ICH Q10 Implementation

N Calnan, A Greene, PE Kane - A Lifecycle Approach to …, 2017 - taylorfrancis.com
This chapter focuses on understanding the implementation essentials necessary to deliver
an 'effective quality management system for the pharmaceutical industry' and the crucial role …

FDA Quality Metrics Research Final Report Year 2

T Friedli, S Köhler, P Buess, S Eich, P Basu, N Calnan - 2018 - alexandria.unisg.ch
This report, building upon the findings of the first year of the research project provides an
account of the research activities undertaken in the second year and presents an outlook for …

[PDF][PDF] 21c Quality Management in the Pharmaceutical Industry

T Friedli, PK Basu, C Mänder, N Calnan, S Biehl… - 2018 - ecv.de
… The recent regulatory, industry and even media focus on developing the rightculture of
quality runs the risk of denigrating the idea of culture change to little more than a slogan (Calnan …

Overview of the recent FDA Process Validation Guidance for Medicinal Product Development and Manufacture

N Calnan - 2013 - arrow.tudublin.ie
This conference paper presents an overview of the recently published FDA Process Validation
Guideline for the development and manufacture of medicinal drug products. It discusses …